201 results
8-K
EX-10.1
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
, customer lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any
8-K
EX-10.2
DMKPQ
DMK Pharmaceuticals Corp
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
, lists, customer lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions
DEFC14A
DMKPQ
DMK Pharmaceuticals Corp
12 Oct 23
Proxy in contested solicitation
4:22pm
levels; economic value added (or an equivalent metric); market share; cash flow; cash flow per share; share price performance; debt reduction; customer … performance; (22) debt reduction; (23) customer satisfaction; (24) stockholders’ equity; (25) capital expenditures; (26) debt levels; (27) operating profit
PREC14A
jf1u5mczyelsv1lg3
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
8-K
EX-10.1
1y39k6fozd0wd
29 Aug 23
Entry into a Material Definitive Agreement
4:30pm
424B4
8gjt7 v5d
3 Aug 23
Prospectus supplement with pricing info
4:55pm
8-K
EX-10.2
td00586k259sz97
24 Jul 23
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-10.2
l4v xih4s58u
26 May 23
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
4:25pm
DEFM14A
i61mf foj6e7phaz6
13 Apr 23
Proxy related to merger
4:52pm